KoreaTechToday - Korea's Leading Tech and Startup Media Platform
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists
No Result
View All Result
KoreaTechToday - Korea's Leading Tech and Startup Media Platform
No Result
View All Result
Home Biotech

Samsung Biologics Signs 287 Bln Won CMO Supply Deal with GSK

 1,785 total views,  1 views today

James Jung by James Jung
PUBLISHED: May 22, 2020 UPDATED: May 22, 2020
in Biotech, Healthcare, Medical, Samsung, Samsung Biologics, South Korea
0
Samsung Biologics signs CMO deal with GSK to supply biopharmaceutical products.
Samsung Biologics signs CMO deal with GSK to supply biopharmaceutical products.

Samsung Biologics signs CMO deal with GSK to supply biopharmaceutical products.

Samsung Biologics Co. on Friday said that it signed an eight-year contract manufacturing organization (CMO) deal valued at 287 billion won ($231 million) with GlaxoSmithKline PLC (GSK) to supply biopharmaceutical products.

Under the CMO agreement, Samsung Group’s biopharmaceutical affiliate would commercially manufacture GSK’s lupus treatment drug named Benlysta (belimumab), starting in 2022. The company said that upon GSK’s request, it could expand to making other drugs for the British pharmaceutical company.

Lupus is an autoimmune disease in which the person’s immune system becomes hyperactive and attacks normal and healthy tissue and organs.

Regis Simard, president of GSK’s pharmaceuticals supply chain, said that the agreement with Samsung Biologics strengthened its world-renowned pharmaceutical manufacturing capability. The CMO would also help the company to continue to provide its transformative medicines.

Samsung Biologics also announced that it secured another CMO deal worth 186 billion won ($150 million) with an unspecified U.S.-based partner. The agreement would have Samsung Biologics make the U.S. company’s biologic drug at its No. 3 plant.

Under the mutual agreement, Samsung would keep the details of the contract confidential until December 31, 2023. The company added that depending on further talks, the deal could rise to 276 billion won ($222 million) in the long term.

Last April, Samsung Biologics secured an order from U.S.-based Vir Biotechnology Inc. worth 442 billion won ($358 million) to manufacture antibodies that could potentially cure COVID-19.

Samsung Biologics’ chief executive Kim Tae-han said that the company feels excited and proud of the announcement of the long-term CMO with GSK.

Besides CMOs, Samsung Biologics also participates in contract research organization (CRO) and contract development organization (CDO) sectors.

Currently, the Samsung Group subsidiary operates three plants located in Incheon, which could produce 362,000 liters of biosimilars yearly. This makes Samsung Biologics the largest maker of biologic medical products.

What’s your thoughts?
+1
0
+1
0
+1
0
+1
0
+1
0
+1
0
+1
0
Tags: $231 million287 billion wonbiologicsCMOdealdrugGSKlupusSamsungSamsung Biologics

Related Posts

Korean FTC Slaps Broadcom With $14.3M Fine Over Unfair Samsung Deal
Samsung Biologics signs CMO deal with GSK to supply biopharmaceutical products.
Broadcom

Korean FTC Slaps Broadcom With $14.3M Fine Over Unfair Samsung Deal

September 22, 2023
Samsung Unveils 2024 Generative AI Roadmap for Home Appliances
Samsung Biologics signs CMO deal with GSK to supply biopharmaceutical products.
Samsung

Samsung Unveils 2024 Generative AI Roadmap for Home Appliances

September 5, 2023
Top 8 Collaborative Initiatives Fostering Innovation Among South Korea’s Tech Giants
Samsung Biologics signs CMO deal with GSK to supply biopharmaceutical products.
government

Top 8 Collaborative Initiatives Fostering Innovation Among South Korea’s Tech Giants

August 31, 2023
Korea’s Tech Investment Soars: $3.8 Billion Allocated for 12 Strategic Technologies
Samsung Biologics signs CMO deal with GSK to supply biopharmaceutical products.
government

Korea’s Tech Investment Soars: $3.8 Billion Allocated for 12 Strategic Technologies

August 29, 2023
South Korea’s Battle Against Technology Leaks: Strengthened Regulations and Penalties
Samsung Biologics signs CMO deal with GSK to supply biopharmaceutical products.
government

South Korea’s Battle Against Technology Leaks: Strengthened Regulations and Penalties

August 28, 2023
Samsung Electronics Enters Food Tech with ‘Samsung Food’ AI Nutrition Platform
Samsung Biologics signs CMO deal with GSK to supply biopharmaceutical products.
Food

Samsung Electronics Enters Food Tech with ‘Samsung Food’ AI Nutrition Platform

August 25, 2023
No Result
View All Result

Most Popular

  • Top South Korean Tech Products to Look Out for in 2021

    0 shares
    Share 0 Tweet 0
  • SK Telecom, KT, LG Uplus Start Pre-ordering for Apple’s iPhone SE

    0 shares
    Share 0 Tweet 0
  • 5 Best Korean to English Translation Apps

    0 shares
    Share 0 Tweet 0
  • Netflix Files Civil Lawsuit Against SK Broadband Over Network Fees

    0 shares
    Share 0 Tweet 0
  • KT Corporation to develop Korea’s Wifi AP Market via Intel MOU

    0 shares
    Share 0 Tweet 0
  • Quantum Security Arrives in South Korea Thanks to SK Broadband

    0 shares
    Share 0 Tweet 0
  • Samsung Unveils 2024 Generative AI Roadmap for Home Appliances

    0 shares
    Share 0 Tweet 0
  • 5 All-Time Best Rom-Com K-Dramas to Watch

    0 shares
    Share 0 Tweet 0
  • Top Nine Mobile MMORPG in South Korea for 2020

    0 shares
    Share 0 Tweet 0
  • LG StandbyME Go 27LX5 Introduces A Briefcase-Inspired Portable Display

    0 shares
    Share 0 Tweet 0

PRODUCTS

TESSAN Germany France Travel Power Adapter

Lonely Planet Korea 12

Korean Snack Box Variety Pack

OSULLOC Lovely Tea Gift Box Set

TOPICS

  • Naver
  • Kakao
  • Nexon
  • Netmarble
  • NCsoft
  • Samsung
  • Hyundai

FREE NEWSLETTER

FOLLOW US

  • About Us
  • Cookie policy
  • homepage
  • Privacy Policy
  • Terms of Use

Copyright © 2023 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |

No Result
View All Result
  • Topics
    • Naver
    • Kakao
    • Nexon
    • Netmarble
    • NCsoft
    • Samsung
    • Hyundai
    • SKT
    • LG
    • KT
    • Retail
    • Startup
    • Blockchain
    • government
  • Lists

Copyright © 2023 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |